➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Medtronic
Mallinckrodt
Express Scripts
Harvard Business School
Dow
Boehringer Ingelheim

Last Updated: September 27, 2020

DrugPatentWatch Database Preview

Details for Patent: 9,504,666

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Which drugs does patent 9,504,666 protect, and when does it expire?

Patent 9,504,666 protects CLOROTEKAL and is included in one NDA.

This patent has fifteen patent family members in fourteen countries.

Summary for Patent: 9,504,666
Title:Chloroprocaine-based pharmaceutical composition for repeated intrathecal administration
Abstract: This invention relates to an injectable pharmaceutical composition based on chloroprocaine or salts and/or derivatives thereof for use in central loco-regional anesthesia by intrathecal administration in repeated doses. Unexpectedly, the intrathecal administration in repeated doses of chloroprocaine does not increase the neurotoxicity of this drug in statistically significant manner.
Inventor(s): Mitidieri; Augusto (Lugano, CH), Donati; Elisabetta (Cavallasca, IT), Caronzolo; Nicola (Bissone, CH)
Assignee: SINTETICA S.A. (Mendrisio, CH)
Application Number:14/650,583
Patent Claim Types:
see list of patent claims
Use; Formulation;

Drugs Protected by US Patent 9,504,666

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
B Braun Medical Inc CLOROTEKAL chloroprocaine hydrochloride SOLUTION;INTRATHECAL 208791-001 Sep 26, 2017 RX Yes No   Start Trial   Start Trial Y   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 9,504,666

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
ItalyMI2012A2120Dec 12, 2012
PCT Information
PCT FiledDecember 11, 2013PCT Application Number:PCT/IB2013/060801
PCT Publication Date:June 19, 2014PCT Publication Number: WO2014/091420

International Family Members for US Patent 9,504,666

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina 099443   Start Trial
Australia 2013356855   Start Trial
China 105283222   Start Trial
Israel 239270   Start Trial
Italy MI20122120   Start Trial
South Korea 20150085131   Start Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Dow
McKinsey
Express Scripts
Medtronic
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.